<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Eurofins Scientific Se — News on 6ix</title>
<link>https://6ix.com/company/eurofins-scientific-se</link>
<description>Latest news and press releases for Eurofins Scientific Se on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Fri, 24 Apr 2026 15:45:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/eurofins-scientific-se" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo6836173578dffbe2df13d727.webp</url>
<title>Eurofins Scientific Se</title>
<link>https://6ix.com/company/eurofins-scientific-se</link>
</image>
<item>
<title>Eurofins Launches Seventh Buy-Back Programme of Its Own Shares</title>
<link>https://6ix.com/company/eurofins-scientific-se/news/eurofins-launches-seventh-buy-back-programme-of-its-own-shares</link>
<guid isPermaLink="true">https://6ix.com/company/eurofins-scientific-se/news/eurofins-launches-seventh-buy-back-programme-of-its-own-shares</guid>
<pubDate>Fri, 24 Apr 2026 15:45:00 GMT</pubDate>
<description>LUXEMBOURG, April 24, 2026--Regulatory News: Eurofins Scientific SE (the "Company") (EUFI.PA) (Paris:ERF) announces its intention to launch a new buy-back programme of its own shares (ISIN FR0014000MR3) for a maximum amount representing up to 4.5% of its share capital. The maximum amount meant for the repurchase of the Company’s shares may not exceed a sum corresponding to an amount equivalent to the value of 4.5% of the shares composing the share capital of the Company as of the Board of Direct</description>
</item>
<item>
<title>Eurofins Achieves Organic Growth of 2.6% in Q1 2026, Including Impact of Exceptionally Severe Weather; 2026 and Mid-Term Objectives Reiterated</title>
<link>https://6ix.com/company/eurofins-scientific-se/news/eurofins-achieves-organic-growth-of-26percent-in-q1-2026-including-impact-of-exceptionally-severe-weather-2026-and-mid-term-objectives-reiterated</link>
<guid isPermaLink="true">https://6ix.com/company/eurofins-scientific-se/news/eurofins-achieves-organic-growth-of-26percent-in-q1-2026-including-impact-of-exceptionally-severe-weather-2026-and-mid-term-objectives-reiterated</guid>
<pubDate>Wed, 22 Apr 2026 05:15:00 GMT</pubDate>
<description>LUXEMBOURG, April 22, 2026--Regulatory News: The Eurofins (Paris:ERF) network of companies delivered steady growth despite significant temporary headwinds:</description>
</item>
<item>
<title>Eurofins to Divest Its Electrical & Electronic Testing Business</title>
<link>https://6ix.com/company/eurofins-scientific-se/news/eurofins-to-divest-its-electrical-and-electronic-testing-business-1</link>
<guid isPermaLink="true">https://6ix.com/company/eurofins-scientific-se/news/eurofins-to-divest-its-electrical-and-electronic-testing-business-1</guid>
<pubDate>Tue, 14 Apr 2026 05:15:00 GMT</pubDate>
<description>LUXEMBOURG, April 14, 2026--Regulatory News: Eurofins Scientific SE (the "Company" or "Eurofins") (EUFI.PA) (Paris:ERF) announces the signing of an agreement to divest its Electrical & Electronic Testing business ("MET Labs") to UL Solutions Inc. for an Enterprise Value of €575 million on a cash and debt free basis. MET Labs is expected to generate over €180 million in revenues in 2026, with profitability broadly in line with the Group average, and employs approximately 1,300 staff globally.</description>
</item>
<item>
<title>Eurofins Scientific SE: Weekly report on Share Repurchases on 30th March 2026</title>
<link>https://6ix.com/company/eurofins-scientific-se/news/eurofins-scientific-se-weekly-report-on-share-repurchases-on-30th-march-2026-1</link>
<guid isPermaLink="true">https://6ix.com/company/eurofins-scientific-se/news/eurofins-scientific-se-weekly-report-on-share-repurchases-on-30th-march-2026-1</guid>
<pubDate>Tue, 07 Apr 2026 15:45:00 GMT</pubDate>
<description>LUXEMBOURG, April 07, 2026--Regulatory News: Eurofins Scientific SE (Paris:ERF):</description>
</item>
<item>
<title>Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 31 March 2026</title>
<link>https://6ix.com/company/eurofins-scientific-se/news/eurofins-scientific-se-disclosure-of-total-number-of-voting-rights-and-number-of-shares-in-the-capital-at-31-march-2026-1</link>
<guid isPermaLink="true">https://6ix.com/company/eurofins-scientific-se/news/eurofins-scientific-se-disclosure-of-total-number-of-voting-rights-and-number-of-shares-in-the-capital-at-31-march-2026-1</guid>
<pubDate>Fri, 03 Apr 2026 09:58:00 GMT</pubDate>
<description>LUXEMBOURG, April 03, 2026--Regulatory News: Eurofins Scientific SE (Paris:ERF):</description>
</item>
<item>
<title>Eurofins Announces the Cancellation of 6.163M Repurchased Shares</title>
<link>https://6ix.com/company/eurofins-scientific-se/news/eurofins-announces-the-cancellation-of-6163m-repurchased-shares-1</link>
<guid isPermaLink="true">https://6ix.com/company/eurofins-scientific-se/news/eurofins-announces-the-cancellation-of-6163m-repurchased-shares-1</guid>
<pubDate>Wed, 01 Apr 2026 05:15:00 GMT</pubDate>
<description>LUXEMBOURG, April 01, 2026--Regulatory News: Eurofins Scientific SE (the "Company" or "Eurofins") (EUFI.PA) (Paris:ERF) announces that its Board of Directors has decided on the cancellation of 6,163,000 shares, representing 3.38% of the Company’s share capital, that were repurchased as part of its share buyback programmes, which began in October 2022.</description>
</item>
<item>
<title>Eurofins Scientific SE: Weekly Report on Share Repurchases from 23th March to 27th March 2026</title>
<link>https://6ix.com/company/eurofins-scientific-se/news/eurofins-scientific-se-weekly-report-on-share-repurchases-from-23th-march-to-27th-march-2026-1</link>
<guid isPermaLink="true">https://6ix.com/company/eurofins-scientific-se/news/eurofins-scientific-se-weekly-report-on-share-repurchases-from-23th-march-to-27th-march-2026-1</guid>
<pubDate>Mon, 30 Mar 2026 15:45:00 GMT</pubDate>
<description>LUXEMBOURG, March 30, 2026--Regulatory News: Eurofins Scientific SE (Paris:ERF):</description>
</item>
<item>
<title>Eurofins Scientific: Director/PDMR Shareholding</title>
<link>https://6ix.com/company/eurofins-scientific-se/news/eurofins-scientific-directorpdmr-shareholding-2</link>
<guid isPermaLink="true">https://6ix.com/company/eurofins-scientific-se/news/eurofins-scientific-directorpdmr-shareholding-2</guid>
<pubDate>Thu, 26 Mar 2026 13:21:00 GMT</pubDate>
<description>LUXEMBOURG, March 26, 2026--Eurofins Scientific SE (EUFI.PA) has received various notifications of dealing from Persons Discharging Managerial Responsibilities ("PDMR"). The notification of Dealing Form for each PDMR can be found below.</description>
</item>
<item>
<title>CORRECTING and REPLACING: Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 31 January 2026 - Erratum</title>
<link>https://6ix.com/company/eurofins-scientific-se/news/correcting-and-replacing-eurofins-scientific-se-disclosure-of-total-number-of-voting-rights-and-number-of-shares-in-the-capital-at-31-january-2026-erratum-1</link>
<guid isPermaLink="true">https://6ix.com/company/eurofins-scientific-se/news/correcting-and-replacing-eurofins-scientific-se-disclosure-of-total-number-of-voting-rights-and-number-of-shares-in-the-capital-at-31-january-2026-erratum-1</guid>
<pubDate>Wed, 25 Mar 2026 14:30:00 GMT</pubDate>
<description>LUXEMBOURG, March 25, 2026--Regulatory News: This replaces the announcement made on 11 February 2026 due to the following correction: updated number of voting rights.</description>
</item>
<item>
<title>CORRECTING and REPLACING: Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 28 February 2026 - Erratum</title>
<link>https://6ix.com/company/eurofins-scientific-se/news/correcting-and-replacing-eurofins-scientific-se-disclosure-of-total-number-of-voting-rights-and-number-of-shares-in-the-capital-at-28-february-2026-erratum-1</link>
<guid isPermaLink="true">https://6ix.com/company/eurofins-scientific-se/news/correcting-and-replacing-eurofins-scientific-se-disclosure-of-total-number-of-voting-rights-and-number-of-shares-in-the-capital-at-28-february-2026-erratum-1</guid>
<pubDate>Wed, 25 Mar 2026 14:08:00 GMT</pubDate>
<description>LUXEMBOURG, March 25, 2026--Regulatory News: This replaces the announcement made on 6 March 2026 due to the following correction: updated number of voting rights.</description>
</item>
<item>
<title>Eurofins Scientific SE: Weekly Report on Share Repurchases From 16th March to 20th March 2026</title>
<link>https://6ix.com/company/eurofins-scientific-se/news/eurofins-scientific-se-weekly-report-on-share-repurchases-from-16th-march-to-20th-march-2026-1</link>
<guid isPermaLink="true">https://6ix.com/company/eurofins-scientific-se/news/eurofins-scientific-se-weekly-report-on-share-repurchases-from-16th-march-to-20th-march-2026-1</guid>
<pubDate>Mon, 23 Mar 2026 16:45:00 GMT</pubDate>
<description>LUXEMBOURG, March 23, 2026--Regulatory News: Eurofins Scientific SE (Paris:ERF):</description>
</item>
<item>
<title>Eurofins Scientific SE: Weekly Report on Share Repurchases From 09th March to 13th March 2026</title>
<link>https://6ix.com/company/eurofins-scientific-se/news/eurofins-scientific-se-weekly-report-on-share-repurchases-from-09th-march-to-13th-march-2026-1</link>
<guid isPermaLink="true">https://6ix.com/company/eurofins-scientific-se/news/eurofins-scientific-se-weekly-report-on-share-repurchases-from-09th-march-to-13th-march-2026-1</guid>
<pubDate>Mon, 16 Mar 2026 16:45:00 GMT</pubDate>
<description>LUXEMBOURG, March 16, 2026--Regulatory News: Eurofins (Paris:ERF):</description>
</item>
<item>
<title>Eurofins Biomnis Launches New Clinical LC‑MS/MS Method for the Detection of Cereulide Toxin in Stool Samples</title>
<link>https://6ix.com/company/eurofins-scientific-se/news/eurofins-biomnis-launches-new-clinical-lcmsms-method-for-the-detection-of-cereulide-toxin-in-stool-samples-1</link>
<guid isPermaLink="true">https://6ix.com/company/eurofins-scientific-se/news/eurofins-biomnis-launches-new-clinical-lcmsms-method-for-the-detection-of-cereulide-toxin-in-stool-samples-1</guid>
<pubDate>Wed, 11 Mar 2026 08:00:00 GMT</pubDate>
<description>LYON, France, March 11, 2026--Eurofins Biomnis, a leading European provider of specialised clinical diagnostics services, and part of the global network of Eurofins laboratories, announces the successful development and validation of a new liquid chromatography tandem mass spectrometry (LC‑MS/MS) method for the detection and quantification of cereulide toxin in human stool samples.</description>
</item>
<item>
<title>Eurofins Scientific SE: Weekly Report on Share Repurchases from 02nd March to 06th March 2026</title>
<link>https://6ix.com/company/eurofins-scientific-se/news/eurofins-scientific-se-weekly-report-on-share-repurchases-from-02nd-march-to-06th-march-2026-1</link>
<guid isPermaLink="true">https://6ix.com/company/eurofins-scientific-se/news/eurofins-scientific-se-weekly-report-on-share-repurchases-from-02nd-march-to-06th-march-2026-1</guid>
<pubDate>Mon, 09 Mar 2026 16:45:00 GMT</pubDate>
<description>LUXEMBOURG, March 09, 2026--Regulatory News: Eurofins Scientific SE (Paris:ERF):</description>
</item>
<item>
<title>Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 28 February 2026</title>
<link>https://6ix.com/company/eurofins-scientific-se/news/eurofins-scientific-se-disclosure-of-total-number-of-voting-rights-and-number-of-shares-in-the-capital-at-28-february-2026-1</link>
<guid isPermaLink="true">https://6ix.com/company/eurofins-scientific-se/news/eurofins-scientific-se-disclosure-of-total-number-of-voting-rights-and-number-of-shares-in-the-capital-at-28-february-2026-1</guid>
<pubDate>Fri, 06 Mar 2026 11:41:00 GMT</pubDate>
<description>LUXEMBOURG, March 06, 2026--Regulatory News: Eurofins Scientific SE (Paris:ERF):</description>
</item>
<item>
<title>Eurofins Scientific SE: Weekly Report on Share Repurchases from 23rd February to 27th February 2026</title>
<link>https://6ix.com/company/eurofins-scientific-se/news/eurofins-scientific-se-weekly-report-on-share-repurchases-from-23rd-february-to-27th-february-2026-1</link>
<guid isPermaLink="true">https://6ix.com/company/eurofins-scientific-se/news/eurofins-scientific-se-weekly-report-on-share-repurchases-from-23rd-february-to-27th-february-2026-1</guid>
<pubDate>Mon, 02 Mar 2026 16:45:00 GMT</pubDate>
<description>LUXEMBOURG, March 02, 2026--Regulatory News: Eurofins Scientific SE (Paris:ERF):</description>
</item>
<item>
<title>Eurofins announces the publication of its 2025 Annual Report and 2025 Environmental, Social and Governance Report</title>
<link>https://6ix.com/company/eurofins-scientific-se/news/eurofins-announces-the-publication-of-its-2025-annual-report-and-2025-environmental-social-and-governance-report-1</link>
<guid isPermaLink="true">https://6ix.com/company/eurofins-scientific-se/news/eurofins-announces-the-publication-of-its-2025-annual-report-and-2025-environmental-social-and-governance-report-1</guid>
<pubDate>Thu, 26 Feb 2026 06:15:00 GMT</pubDate>
<description>LUXEMBOURG, February 26, 2026--Regulatory News: Eurofins (Paris:ERF) has filed its 2025 Annual Report and its 2025 Environmental, Social and Governance Report for the year ended 31 December 2025 with the electronic database of the Luxembourg Stock Exchange (www.bourse.lu) on 26 February 2026. They are available on the Eurofins website, www.eurofins.com, under the heading Investors / Results and Presentations.</description>
</item>
<item>
<title>Eurofins Scientific SE: Weekly Report on Share Repurchases from 16th February to 20th February 2026</title>
<link>https://6ix.com/company/eurofins-scientific-se/news/eurofins-scientific-se-weekly-report-on-share-repurchases-from-16th-february-to-20th-february-2026-1</link>
<guid isPermaLink="true">https://6ix.com/company/eurofins-scientific-se/news/eurofins-scientific-se-weekly-report-on-share-repurchases-from-16th-february-to-20th-february-2026-1</guid>
<pubDate>Mon, 23 Feb 2026 16:45:00 GMT</pubDate>
<description>LUXEMBOURG, February 23, 2026--Regulatory News: Eurofins Scientific SE (Paris:ERF):</description>
</item>
<item>
<title>Eurofins Scientific : Director/PDMR Shareholding</title>
<link>https://6ix.com/company/eurofins-scientific-se/news/eurofins-scientific-directorpdmr-shareholding</link>
<guid isPermaLink="true">https://6ix.com/company/eurofins-scientific-se/news/eurofins-scientific-directorpdmr-shareholding</guid>
<pubDate>Mon, 16 Feb 2026 17:23:00 GMT</pubDate>
<description>LUXEMBOURG, February 16, 2026--Eurofins Scientific SE (EUFI.PA) (Paris:ERF) has received various notifications of dealing from Persons Discharging Managerial Responsibilities ("PDMR"). The notification of Dealing Form for each PDMR can be found below.</description>
</item>
<item>
<title>Eurofins: Weekly Report on Share Repurchases From 09th February to 13th February 2026</title>
<link>https://6ix.com/company/eurofins-scientific-se/news/eurofins-weekly-report-on-share-repurchases-from-09th-february-to-13th-february-2026</link>
<guid isPermaLink="true">https://6ix.com/company/eurofins-scientific-se/news/eurofins-weekly-report-on-share-repurchases-from-09th-february-to-13th-february-2026</guid>
<pubDate>Mon, 16 Feb 2026 16:45:00 GMT</pubDate>
<description>LUXEMBOURG, February 16, 2026--Regulatory News: Eurofins (Paris:ERF):</description>
</item>
</channel>
</rss>